Zinzino Reports 15% Revenue Growth in August Preliminary Figures
Zinzino has released preliminary sales results for August 2026, showing group revenue of $28 million, up 15% year over year. South America led regional growth with a 323% increase, while Central Europe remains the company's largest market on a year-to-date basis.
Monthly figures
Zinzino has published its preliminary sales results for August 2026. Total group revenue grew 15% year over year to $28 million.
Within that total, the company's own sales markets accounted for approximately $27.9 million, a 16% increase compared with the same month a year earlier.
External sales at Faun Pharma moved in the opposite direction, declining from roughly $338,000 to about $130,000.
Year-to-date performance
Across the first eight months of 2026, cumulative revenue reached $245 million, a 22% increase on the comparable period.
The figures remain preliminary, as is customary for the company's monthly sales disclosures ahead of full reporting.
Regional breakdown
The strongest year-over-year growth came from South America, covering Peru and Colombia, where revenue expanded 323%.
North America, comprising Canada, the United States and Mexico, posted 59% growth, while Central Europe, made up of Austria, Germany and Switzerland, recorded a 32% increase. South Africa grew 18%.
Measured by cumulative revenue since the start of the year, Central Europe is the company's largest market with $73 million. The South and West Europe region ranks second at $40 million, a grouping that covers Cyprus, France, Greece, Italy, Luxembourg, Malta, the Netherlands, Slovenia, Portugal, Spain, the United Kingdom, Belgium, Ireland, Serbia, Turkey and the Canary Islands.
Advertisement
